mortality/aging
• mean survival of pIpC-treated mice is 99 days compared with 150 days for Gt(Rosa)26Sortm4(CAG-hsb5)Nki Gt(Rosa)26Sor+ Tg(Mx1-cre)1Cgn TgTn(pb-sb-GrOnc)#aGsva control mice
|
neoplasm
• all mice develop aggressive leukemia and/or lymphoma within a year of pIpC induction
|
• in pIpC-treated mice
|
• all mice develop aggressive leukemia and/or lymphoma within a year of pIpC induction
• however, pIpC-treated mice do not develop T cell lymphomas unlike in control mice
|
• in some pIpC-treated mice
|
• angiosarcoma in some pIpC-treated mice
|